HopeStage
Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
More filters: keywords, city, remote
1326studies shown
Showing 373-384 of 1,326
Drug study icon
CompletedEUCTR 2009-016667-11

A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 and 200 mg/day) as Adjunctive Therapy in Adults With Major D...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In France
Bipolarity, DepressionHistorical research record
Countries
France, Bulgaria, Spain
Sponsor
Cephalon, Inc.
Drug study icon
CompletedNCT00700427

A Long Term Study of a Medication for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Official study title

Maintenance of Response After Open-Label Treatment With Atomoxetine Hydrochloride in Adult Outpatients With Attention-Deficit/Hyperactivity Disorder (ADHD): A Placebo-Controlled, Randomized Withdrawal Study

This study has finished and is no longer accepting participants.

In France
ADHDMedication studyAges 18–50
Countries
France, United Kingdom, Switzerland, + 9 others
Sponsor
Eli Lilly and Company
Drug study icon
TerminatedNCT01487083

A Long-Term Safety Study of Pomaglumetad Methionil in Schizophrenia

What is this study about?

Researchers are studying Pomaglumetad methionil, tracking side effects to assess long-term safety in people with schizophrenia.

This study ended early.

In France
SchizophreniaMedication studyAges 18–65
Countries
France, United States, Austria, + 7 others
Sponsor
Denovo Biopharma LLC
Drug study icon
CompletedEUCTR 2015-005282-22

A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Adaptive Dose-Finding Study to Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In France
DepressionHistorical research record
Countries
France, Bulgaria, Finland, + 1 other
Sponsor
Janssen-Cilag International NV
Drug study icon
CompletedEUCTR 2007-002111-82

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Response Study to Evaluate Efficacy and Safety of Prolonged Release (PR) OROS® methylphenidate (54 and 72 mg/day) i...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In France
ADHDHistorical research record
Countries
France, United Kingdom, Belgium, + 6 others
Sponsor
Janssen-Cilag International N.V., Turnhoutseweg 30, B-2340 Beerse, Belgium
Other study type icon
CompletedNCT01959659

A Non-Interventional Study of people with Persistent Symptoms of Schizophrenia to Describe Medical Resource Utilization and Burden of Illness

What is this study about?

This completed observational study examined healthcare use and the impact of persistent schizophrenia symptoms despite adequately dosed antipsychotic treatment.

This study has finished and is no longer accepting participants.

In France
SchizophreniaObservational studyAges 18+
Countries
France, Australia, Czechia, + 4 others
Sponsor
Hoffmann-La Roche

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.